Richard Mph
Chief Medical Officer at Lyndra Therapeutics | Acton, Massachusetts, United States
Engage
candidates 10x faster
Enjoy unlimited access and discover candidates outside of LinkedIn
Trusted by 1.4M users from 76% of Fortune 500 companies
The most accurate data ever
CCPA Compliant
GDPR Compliant
150M
Personal Emails
200M
Work Emails
100M
Direct Dials
250M
Professional Profiles
40M
Company Profiles
Find anyone, anywhere
with ContactOut
today
Making remote or global hires?
Connecting
with key decision-makers? We can help.
- 40 emails / month
- 3 phone numbers / month
- Works on standard LinkedIn only
-
Work emails, personal emails,
mobile numbers
No credit card required
As the Chief Medical Officer at Lyndra Therapeutics, Richard Mph plays a pivotal role in steering the company's innovative approach to drug delivery and therapeutic development. With over 21 years of extensive experience in pharmaco-epidemiologic research and clinical trials, Richard leverages his deep expertise in chronic disease management—particularly in cardiovascular health, diabetes, and obesity—to guide the global clinical development of Lyndra's cutting-edge platform technology. His leadership is instrumental in advancing clinical programs that prioritize patient outcomes, utilizing his proficiency in health economics and patient-reported outcomes to ensure that therapies not only meet regulatory standards but also address real-world patient needs.
Richard's comprehensive understanding of both FDA and EU regulatory frameworks enhances Lyndra's ability to navigate complex approval processes efficiently, ensuring that innovative treatments reach the market in a timely manner. His commitment to excellence in Good Clinical Practice (GCP) and health services research underpins the rigorous methodologies employed in clinical trials, fostering a culture of safety and efficacy. Additionally, Richard's expertise in health technology assessment (HTA) positions Lyndra to effectively communicate the value of its therapies to key opinion leaders (KOLs) and stakeholders across the healthcare landscape.
Under Richard's guidance, Lyndra Therapeutics is not only advancing its pipeline of novel therapeutics but is also setting new standards in the biotechnology sector for patient-centric drug development. His strategic vision and collaborative approach are essential as the company continues to innovate and redefine the future of chronic disease management.
Chief Medical Officer at Lyndra Therapeutics in January 2020 to Present
President Global Product Development at Lyndra Therapeutics in July 2023 to Present
Chief Medical Officer at Pacira BioSciences, Inc. in June 2018 to January 2021
Chief Scientific Officer at Pacira BioSciences, Inc. in May 2017 to January 2020
Executive Medical Director at Pacira BioSciences, Inc. in November 2011 to January 2020
Vice President Clincial and Scientific Affairs at Pacira BioSciences, Inc. in March 2013 to May 2017
Chief Medical Officer at VeroScience in July 2006 to November 2011
Associate Physician at Brigham and Women's Hospital in July 2002 to July 2010
Assistant Professor in Medicine at Division of Aging, Brigham and Women's, Harvard Medical School in June 2002 to July 2010
Director Research at Veteran Affairs Boston Healthcare System in June 2002 to July 2006
Associate Director at Phase V Technology in January 2002 to January 2006
Lieutenant Commander Medical Corp at US Navy in June 1994 to June 2000
See more
See less
Pharmacoepidemiology
Outcomes Research
Pharmacovigilance
Medical Education
KOL development
Patient Reported Outcomes
Clinical Trials
Health Economics
Epidemiology
Clinical Research
Clinical Development
Endocrinology
Neurology
Medical Affairs
Pharmacoeconomics
Infectious Diseases
Protocol
GCP
Health Policy
Dermatology
Pharmaceutical Industry
Clinical Study Design
FDA
Evidence-based Medicine
Neuroscience
Medicine
Diabetes
Lifesciences
Medical Writing
Medical Research
Gastroenterology
Immunology
Informatics
Cancer
Hematology
Health Services Research
HTA
Drug Development
Internal Medicine
Cardiology
Hospitals
Biostatistics
CRO
Biotechnology
CTMS
Nephrology
Rheumatology
Therapeutic Areas
Translational Research
Vaccines
See more
See less
Discover more about Lyndra TherapeuticsWhat is Richard Mph email address?
Email Richard Mph at [email protected] and [email protected]. This email is the most updated Richard Mph email found in 2026.
What is Richard Mph phone number?
Richard Mph phone number is +16178528423 and +13092552228.
How to contact Richard Mph?
To contact Richard Mph send an email to [email protected] or [email protected]. If you want to call Richard Mph try calling on +16178528423 and +13092552228.
What is Richard Mph net worth?
Richard Mph has an estimated net worth of $750,000 to $999,999
What company does Richard Mph work for?
Richard Mph works for Lyndra Therapeutics
What is Richard Mph's role at Lyndra Therapeutics?
Richard Mph is Chief Medical Officer
What industry does Richard Mph work in?
Richard Mph works in the Biotechnology Research industry.
Richard Mph Email Addresses
Richard Mph Phone Numbers
looking for?
Find personal and work emails for over 250M professionals.
People like Richard Mph
Community Services at Multiple
Sales Manager at Google
Senior Vice President - Client Success Leader at QualiZeal
Business Intelligence and Data Analytics Lead at BeneLynk
Pharmacist at Kaiser Permanente
Principal Architect at Snowflake
Yoga Fitness Instructor at Esenem Yoga
Sales Executive at Instacart
Geospatial Analyst (Emergency Management Specialist) at FEMA
Privacy & Measurement Team Lead, Product & Sales Activation - Americas, Google Customer Solutions at Google
Commercial Division Subcontract Manager at Hill & Wilkinson General Contractors
Nanny at In home Nanny
A/P at WMC/NEPSI
Director at Capgemini
Vending Machine Owner at A1 Custom Metals #2
Manager Service Contracts at Advanced Sterilization Products
Neonatologist at Sutter Medical Group
Sales And Leasing Consultant at Zimbrick Fish Hatchery Road
Teacher at Edinburg ISD
Assistant Director, American Law Division at Congressional Research Service
Show more
Show less